摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-chloro-4-methylnaphthalene | 104415-92-1

中文名称
——
中文别名
——
英文名称
2-chloro-4-methylnaphthalene
英文别名
3-chloro-1-methylnaphthalene;3-Chlor-1-methyl-naphthalin
2-chloro-4-methylnaphthalene化学式
CAS
104415-92-1
化学式
C11H9Cl
mdl
——
分子量
176.645
InChiKey
OXAHAOCNSXWPED-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.2
  • 重原子数:
    12
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.09
  • 拓扑面积:
    0
  • 氢给体数:
    0
  • 氢受体数:
    0

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • [EN] TETRAZOLINONE COMPOUNDS AND ITS USE AS PESTICIDES<br/>[FR] COMPOSÉS DE TÉTRAZOLINONE ET LEUR UTILISATION EN TANT QUE PESTICIDES
    申请人:SUMITOMO CHEMICAL CO
    公开号:WO2013162072A1
    公开(公告)日:2013-10-31
    The present invention provides a compound having an excellent efficacy for controlling pests. A tetrazolinone compound of a formula (1): [wherein R1 represents an C6-C16 aryl group, an C1-C12 alkyl group, or a C3-C12 cycloalkyl group, etc., which each optionally be substituted; R2, R3, R4 and R5 represent independently of each other a hydrogen atom, a halogen atom or an C1-C3 alkyl group, etc.; R6 represents an C1-C6 alkyl group, a C3-C6 cycloalkyl group, a halogen atom, a C1-C6 haloalkyl group, an C2-C6 alkenyl group, an C1-C6 alkoxy group, or a C1-C6 haloalkoxy group, etc.; R7, R8 and R9 represent independently of each other a hydrogen atom, a halogen atom, or an C1-C4 alkyl group, etc.; X represents an oxygen atom or a sulfur atom; and R10 represents an C1-C6 alkyl group, etc.] shows an excellent controlling efficacy on pests.
    本发明提供了一种具有优异杀虫效果的化合物。公式(1)的四唑酮化合物:[其中R1代表C6-C16芳基、C1-C12烷基或C3-C12环烷基等,每个都可以选择性地被取代;R2、R3、R4和R5分别独立地代表氢原子、卤素原子或C1-C3烷基等;R6代表C1-C6烷基、C3-C6环烷基、卤素原子、C1-C6卤代烷基、C2-C6烯基、C1-C6烷氧基或C1-C6卤代烷氧基等;R7、R8和R9分别独立地代表氢原子、卤素原子或C1-C4烷基等;X代表氧原子或硫原子;R10代表C1-C6烷基等]在杀虫方面表现出优异的控制效果。
  • INHIBITORS OF TISSUE TRANSGLUTAMINASE 2 (TG2) AND USES THEREOF
    申请人:Northwestern University
    公开号:US20210276960A1
    公开(公告)日:2021-09-09
    Disclosed are compounds, pharmaceutical compositions comprising the compounds, and methods of using the compounds and pharmaceutical compositions for treating a subject in need thereof. The disclosed compounds inhibit the activity of tissue transglutaminase 2 (TG2). As such, the disclosed compounds and pharmaceutical compositions may be utilized in methods for treating a subject having or at risk for developing a disease or disorder that is associated with TG2 activity which may be cell proliferative diseases and disorders such as cancer.
    揭示了化合物、包含这些化合物的药物组合物,以及利用这些化合物和药物组合物治疗需要的受试者的方法。所述的化合物抑制组织转谷氨酰胺酶2(TG2)的活性。因此,这些揭示的化合物和药物组合物可以用于治疗患有或有发展与TG2活性相关的疾病或紊乱的受试者的方法,这些疾病或紊乱可能是与细胞增殖相关的疾病或紊乱,如癌症。
  • 2,2 (Diarlyl) Vinylphosphine compound, palladium catalyst thereof, and process for producing arylamine, diaryl, or arylalkyne with the catalyst
    申请人:——
    公开号:US20020058837A1
    公开(公告)日:2002-05-16
    A novel 2,2-(diaryl)vinylphosphine compound represented by the following general formula (1): 1 (wherein R 1 is a hydrogen atom, an alkyl group having 1 to 6 carbon atoms, an alicyclic group having 5 to 7 carbon atoms, etc.; R 2 , R 3 , R 4 , R 5 , R 6 , and R 7 may be the same or different and each is an alkyl group having 1 to 6 carbon atoms, an alicyclic group having 5 to 7 carbon atoms, etc., provided that R 4 and R 5 taken together and/or R 6 and R 7 taken together may represent a fused benzene ring, a substituted fused benzene ring, a trimethylene group, etc.; and p, q, r, and s each is 0 to 5, provided that p+q and r+s each is in the range of from 0 to 5); a palladium-phosphine catalyst obtained by causing a palladium compound to act on the novel 2,2-(diaryl)vinylphosphine compound; and a process for obtaining an arylamine, a diaryl and an arylalkyne in the presence of the palladium-phosphine catalyst.
    一种由以下通用公式(1)表示的新型2,2-(二芳基)乙烯膦化合物:其中R1是氢原子、具有1至6个碳原子的烷基基团、具有5至7个碳原子的脂环基团等;R2、R3、R4、R5、R6和R7可能相同或不同,每个是具有1至6个碳原子的烷基基团、具有5至7个碳原子的脂环基团等,但要求R4和R5一起和/或R6和R7一起可能代表融合苯环、取代融合苯环、三亚甲基基团等;p、q、r和s每个为0至5,但要求p+q和r+s分别在0至5的范围内;通过使钯化合物作用于新型2,2-(二芳基)乙烯膦化合物而获得的钯-膦催化剂;以及在钯-膦催化剂存在下获得芳胺、二芳基和芳基炔的方法。
  • [EN] TETRAZOLINONE COMPOUNDS AND ITS USE<br/>[FR] COMPOSÉS DE TÉTRAZOLINONE ET LEUR UTILISATION
    申请人:SUMITOMO CHEMICAL CO
    公开号:WO2013162077A1
    公开(公告)日:2013-10-31
    The present invention provides a compound having an excellent efficacy for controlling pests. A tetrazolinone compound of a formula (1): [wherein, R1 represents an C6-C16 aryl group, an C1-C12 alkyl group, a C3-C12 cycloalkyl group or an adamantyl group, etc., which each optionally be substituted; R2 represents a hydrogen atom, an C1-C12 alkyl group, or a halogen atom, etc.; R4 and R5 represent independently of each other a hydrogen atom or an C1-C3 alkyl group, etc.; R6, R7, R8 and R9 represent independently of each other a hydrogen atom, a halogen atom, an C1-C12 alkyl group, a C1-C12 haloalkyl group, an C2-C12 alkenyl group, a C3-C12 cycloalkyl group, an C1-C12 alkoxy group or a C1-C12 haloalkoxy group, etc.; X and Y represent independently of each other a sulfur atom or an oxygen atom; Q represents an oxygen atom or a sulfur atom; and R10 represents an C1-C6 alkyl group, etc.] shows an excellent controlling efficacy on pests.
    本发明提供了一种具有优异杀虫效果的化合物。式(1)中的四氮杂酮化合物:[其中,R1代表一个C6-C16芳基,一个C1-C12烷基,一个C3-C12环烷基或一个金刚烷基等,每个都可以选择性地被取代;R2代表一个氢原子,一个C1-C12烷基或一个卤素原子等;R4和R5分别独立地代表一个氢原子或一个C1-C3烷基等;R6、R7、R8和R9分别独立地代表一个氢原子,一个卤素原子,一个C1-C12烷基,一个C1-C12卤代烷基,一个C2-C12烯基,一个C3-C12环烷基,一个C1-C12烷氧基或一个C1-C12卤代烷氧基等;X和Y分别独立地代表一个硫原子或一个氧原子;Q代表一个氧原子或一个硫原子;R10代表一个C1-C6烷基等]对害虫有极佳的控制效果。
  • Pyrrole derivatives useful for farnesyl transferase inhibitors and their preparations
    申请人:LG Life Sciences, Ltd.
    公开号:US06511978B1
    公开(公告)日:2003-01-28
    The present invention relates to a novel pyrrole derivative which shows an inhibitory activity against farnesyl transferase or pharmaceutically acceptable salts or isomers thereof; to a process for preparation of said compound; and to a pharmaceutical composition such as anti-cancer composition, etc. comprising said compound as an active ingredient together with pharmaceutically acceptable carrier.
    本发明涉及一种新型吡咯衍生物,该衍生物显示出对法尼酰转移酶的抑制活性,或其药学上可接受的盐或异构体;以及制备该化合物的过程;以及包括该化合物作为活性成分的药物组合物,例如抗癌组合物等,以及药学上可接受的载体。
查看更多